A Phase III, Observer-Blind, Randomized Clinical Trial of the Efficacy and Safety of APF530 Compared to Aloxi™ for the Prevention of Acute-Onset and Delayed-Onset Chemotherapy-Induced Nausea and Vomiting Following the Administration of Either Moderately or Highly Emetogenic Chemotherapy Regimens

Prospective Randomized Evaluation of Celecoxib Integrated Safety vs. Ibuprofen or Naproxen (PRECISION)

Mark J. Yacyk, DO

Prospective Randomized 12-Week Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Pregabalin or Placebo

A Phase 2 Study of XL647 in Subjects with Non-Small Cell Lung Cancer Who Have Progressed After Responding to Treatment with Either Erlotinib or Gefitinib

A Phase IIb, Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Multicenter Study to Determine the Safety, Tolerance, and Efficacy of AT-1001 in Celiac Disease Subjects during a Gluten Challenge

Nelson L. Ferreira, MD

Michael J. McCormack, MD

William Su, MD

Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Sequential Cohort Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects with Congestive Heart Failure and Impaired Renal Function

Oscar Adler, MD

A Randomized, Double-Blind, Placebo-Controlled Study of AGI-003 (Arverapamil) in the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D)

Nelson L. Ferreira, MD

James Cremins, MD

Nelson L. Ferreira, MD

James Cremins, MD

ADVANCE:  A Randomized Study to Evaluate the Effects of Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects with Chronic Kidney Disease (“CKD”) Receiving Hemodialysis

Oscar Adler, MD

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Dose-Range Exploration Study of Sativex® in Relieving Pain in Patients with Advanced Cancer, Who Experience Inadequate Analgesia during Optimized Chronic Opioid Therapy

Clinical Trial Funded by Yale University Subcontract # A06379 to JHU under NIH Prime Grant # U01 NS044876 (Agency) Entitled: "IRIS: Insulin Resistance Intervention After Stroke Trial"

Mark J. Yacyk, DO

A Multi-center, Randomized, Placebo-Controlled, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients with Opioid-induced  Bowel Dysfunction

Nelson L. Ferreira, MD

Bone Marker Directed Dosing of ZOMETA (zoledronic acid) for the Prevention of Skeletal Complications in Patients with Advanced Multiple Myeloma

Double-Blind, Placebo-Controlled, Dose-Finding Study of the Effect of GTX-024 on Muscle Wasting (Cachexia) in Patients with Cancer

Michael J. McCormack, MD

Trial to Reduce Cardiovascular Events with Aranesp® Therapy:  TREAT

Nelson L. Ferreira, MD

James Cremins, MD

Nelson L. Ferreira, MD

James Cremins, MD      

Nelson L. Ferreira, MD

James Cremins, MD

A Phase III, Multicenter, Open Label, Extension Study to Evaluate the Long-term Safety of Renzapride 4 mg Once Daily in Women with Constipation-Predominant Irritable Bowel Syndrome (c-IBS)

Nelson L. Ferreira, MD

Expanded Access Study of Satraplatin Plus Prednisone in Patients with Hormone Refractory Prostate Cancer Previously Treated with Unlimited Cytotoxic Chemotherapy Regimens

Michael J. McCormack, MD

A Long Term Safety Study of the Vascular Wrap™ Paclitaxel-Eluting Mesh After Surgical Implantation with the Lifespan® ePTFE Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access

Oscar Adler, MD

William Su, MD

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis

Nelson L. Ferreira, MD

A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-Blind, Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis

Nelson L. Ferreira, MD